Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Inflammatory Bowel Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07463183
What this trial is testing

Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

Who this might be right for
Colitis UlcerativeUlcerative Colitis
Merck Sharp & Dohme LLC 100
Large-scale testing (Phase 3)Looking for participantsNCT04779320
What this trial is testing

Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Who this might be right for
Crohn's Disease (CD)
Takeda 120
Not applicableStudy completedNCT04873700
What this trial is testing

Moderate to Severe Inflammatory Bowel Disease, Including Ulcerative Colitis (UC) and Crohn's Disease (CD)

Who this might be right for
Inflammatory Bowel DiseasesColitis, UlcerativeCrohn Disease
Takeda 335
Large-scale testing (Phase 3)Looking for participantsNCT06430801
What this trial is testing

Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Who this might be right for
Crohn's Disease
Merck Sharp & Dohme LLC 1,200
Testing effectiveness (Phase 2)Study completedNCT01482884
What this trial is testing

Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AstraZeneca 147
Large-scale testing (Phase 3)Study completedNCT01369355
What this trial is testing

Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)

Who this might be right for
Crohn's DiseaseColitisIBD+1 more
Janssen Research & Development, LLC 1,282
Early research (Phase 1)UnknownNCT05743010
What this trial is testing

A Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Jiangsu Yahong Meditech Co., Ltd aka Asieris 36
Large-scale testing (Phase 3)Study completedNCT02163759
What this trial is testing

A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors

Who this might be right for
Ulcerative Colitis
Hoffmann-La Roche 358
Large-scale testing (Phase 3)Study completedNCT03009396
What this trial is testing

Open Label Efficacy and Safety of Anti-MAP (Mycobacterium Avium Ssp. Paratuberculosis) Therapy in Adult Crohn's Disease

Who this might be right for
Crohn Disease
RedHill Biopharma Limited 54
Testing effectiveness (Phase 2)WithdrawnNCT04096573
What this trial is testing

Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
LG Chem
Testing effectiveness (Phase 2)Looking for participantsNCT06226883
What this trial is testing

Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Who this might be right for
Inflammatory Bowel DiseasesCrohn's Disease
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) 385
Not applicableUnknownNCT04897282
What this trial is testing

Prospective Multicenter Trial to Determine the Efficacy and Outcome of the UCRI Biomarker Panel and Algorithm to Detect Mucosal Healing in Moderate to Severe Ulcerative Colitis Patients.

Who this might be right for
Ulcerative Colitis
Glycominds, LLC 100
Testing effectiveness (Phase 2)Study completedNCT03695185
What this trial is testing

Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior Therapy

Who this might be right for
Ulcerative Colitis (UC)
AbbVie 42
Testing effectiveness (Phase 2)Looking for participantsNCT06764615
What this trial is testing

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

Who this might be right for
Crohn's DiseaseUlcerative Colitis
Takeda 192
Large-scale testing (Phase 3)Active Not RecruitingNCT06052059
What this trial is testing

Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

Who this might be right for
Ulcerative Colitis
Merck Sharp & Dohme LLC 1,020
Testing effectiveness (Phase 2)Study completedNCT03648541
What this trial is testing

BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Boehringer Ingelheim 79
Large-scale testing (Phase 3)Looking for participantsNCT07071519
What this trial is testing

Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 120
Large-scale testing (Phase 3)Study completedNCT01369329
What this trial is testing

Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)

Who this might be right for
Crohn's DiseaseIBDColitis+1 more
Janssen Research & Development, LLC 769
Not applicableLooking for participantsNCT06073873
What this trial is testing

A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC in Korea

Who this might be right for
Ulcerative Colitis
Bristol-Myers Squibb 3,000
Not applicableLooking for participantsNCT07442045
What this trial is testing

Real-World Effectiveness and Safety of Upadacitinib Plus Vedolizumab vs Upadacitinib Monotherapy During Induction in Moderate-to-Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Sixth Affiliated Hospital, Sun Yat-sen University 150
Next Page